Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

Showing products 1–24 of 41. More products

FLUOXETINE HCL

11 general benefit · 13 not a benefit

Other products in the same Health Canada class (N06A, N06AB) — coverage varies; not interchangeable

  • Citalopram (Celexa): general benefit, Not a benefit
  • Escitalopram (Cipralex MELTZ): general benefit, Not a benefit
  • Fluvoxamine (Luvox): general benefit
  • Paroxetine (Paxil): general benefit, Not a benefit
  • Sertraline (Zoloft): general benefit
  • Amitriptyline (Elavil): general benefit

17 more in the class list below

Ach-Fluoxetine · DIN 02383241 · 20mg · capsule

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Ach-Fluoxetine · DIN 02383241 Manufacturer: Accord Healthcare Inc.; listing date 2012-07-27 Health Canada: Marketed since 2019-09-04 · brand ACH-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 20 MG · company Accord healthcare inc · schedule Prescription
Check this DIN again · Health Canada product record

Ach-Fluoxetine: Formulary list price $0.3311/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.3311 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=86901 · Verify on the e-Formulary ↗ (DIN 02383241)

Source record
DIN 02383241: Ach-Fluoxetine Raw flags: sec3=Y Item: 281604051; group id 461; item number 1155; lccId None; manufacturer id ACH Source form: Cap; strength: 20mg Recorded listing: General benefit Source prices (unrounded): $0.3311; ministry $0.3311 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02383241 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=86901
Interchangeable products
AG-Fluoxetine · DIN 02485060 · $0.3311 Apo-Fluoxetine · DIN 02216361 · $0.3311 Auro-Fluoxetine · DIN 02385635 · $0.3311 Bio-Fluoxetine · DIN 02448432 · $0.3311 Co Fluoxetine · DIN 02242178 · $0.3311 Fluoxetine · DIN 02286076 · $0.3311 Fluoxetine · DIN 02374455 · $0.3311 Jamp-Fluoxetine · DIN 02386402 · $0.3311 M-Fluoxetine · DIN 02529440 · $0.3311 Mar-Fluoxetine · DIN 02392917 · $0.3311 Mint-Fluoxetine · DIN 02380579 · $0.3311 NRA-Fluoxetine · DIN 02503883 · $0.3311 PMS-Fluoxetine · DIN 02177587 · $0.3311 Prozac · DIN 00636622 · not recorded Ran-Fluoxetine · DIN 02405709 · $0.3311 Sandoz Fluoxetine · DIN 02479494 · $0.3311 Teva-Fluoxetine · DIN 02216590 · $0.3311
Shortage status: active shortage (reported 2024-08-20, last updated 2025-04-07); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02383241
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Fluoxetine · DIN 02216361 · 20mg · capsule

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Fluoxetine · DIN 02216361 Manufacturer: Apotex Inc.; listing date 1996-10-01 Health Canada: Marketed since 2022-01-20 · brand APO-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 20 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Fluoxetine: Formulary list price $0.3311/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.3311 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19961 · Verify on the e-Formulary ↗ (DIN 02216361)

Source record
DIN 02216361: Apo-Fluoxetine Raw flags: sec3=Y Item: 281604051; group id 461; item number 1155; lccId None; manufacturer id APX Source form: Cap; strength: 20mg Recorded listing: General benefit Source prices (unrounded): $0.3311; ministry $0.3311 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02216361 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19961
Interchangeable products
AG-Fluoxetine · DIN 02485060 · $0.3311 Ach-Fluoxetine · DIN 02383241 · $0.3311 Auro-Fluoxetine · DIN 02385635 · $0.3311 Bio-Fluoxetine · DIN 02448432 · $0.3311 Co Fluoxetine · DIN 02242178 · $0.3311 Fluoxetine · DIN 02286076 · $0.3311 Fluoxetine · DIN 02374455 · $0.3311 Jamp-Fluoxetine · DIN 02386402 · $0.3311 M-Fluoxetine · DIN 02529440 · $0.3311 Mar-Fluoxetine · DIN 02392917 · $0.3311 Mint-Fluoxetine · DIN 02380579 · $0.3311 NRA-Fluoxetine · DIN 02503883 · $0.3311 PMS-Fluoxetine · DIN 02177587 · $0.3311 Prozac · DIN 00636622 · not recorded Ran-Fluoxetine · DIN 02405709 · $0.3311 Sandoz Fluoxetine · DIN 02479494 · $0.3311 Teva-Fluoxetine · DIN 02216590 · $0.3311
Shortage status: avoided shortage; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02216361
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Auro-Fluoxetine · DIN 02385635 · 20mg · capsule

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Auro-Fluoxetine · DIN 02385635 Manufacturer: Auro Pharma Inc.; listing date 2012-09-28 Health Canada: Marketed since 2012-07-24 · brand AURO-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 20 MG · company Auro pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

Auro-Fluoxetine: Formulary list price $0.3311/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.3311 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87126 · Verify on the e-Formulary ↗ (DIN 02385635)

Source record
DIN 02385635: Auro-Fluoxetine Raw flags: sec3=Y Item: 281604051; group id 461; item number 1155; lccId None; manufacturer id AUR Source form: Cap; strength: 20mg Recorded listing: General benefit Source prices (unrounded): $0.3311; ministry $0.3311 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02385635 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87126
Interchangeable products
AG-Fluoxetine · DIN 02485060 · $0.3311 Ach-Fluoxetine · DIN 02383241 · $0.3311 Apo-Fluoxetine · DIN 02216361 · $0.3311 Bio-Fluoxetine · DIN 02448432 · $0.3311 Co Fluoxetine · DIN 02242178 · $0.3311 Fluoxetine · DIN 02286076 · $0.3311 Fluoxetine · DIN 02374455 · $0.3311 Jamp-Fluoxetine · DIN 02386402 · $0.3311 M-Fluoxetine · DIN 02529440 · $0.3311 Mar-Fluoxetine · DIN 02392917 · $0.3311 Mint-Fluoxetine · DIN 02380579 · $0.3311 NRA-Fluoxetine · DIN 02503883 · $0.3311 PMS-Fluoxetine · DIN 02177587 · $0.3311 Prozac · DIN 00636622 · not recorded Ran-Fluoxetine · DIN 02405709 · $0.3311 Sandoz Fluoxetine · DIN 02479494 · $0.3311 Teva-Fluoxetine · DIN 02216590 · $0.3311
Shortage status: resolved shortage (ended 2023-12-28); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02385635
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Bio-Fluoxetine · DIN 02448432 · 20mg · capsule

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Bio-Fluoxetine · DIN 02448432 Manufacturer: Biomed Pharma; listing date 2016-02-25 Health Canada: Marketed since 2024-12-05 · brand BIO-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 20 MG · company Biomed pharma · schedule Prescription
Check this DIN again · Health Canada product record

Bio-Fluoxetine: Formulary list price $0.3311/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.3311 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=93412 · Verify on the e-Formulary ↗ (DIN 02448432)

Source record
DIN 02448432: Bio-Fluoxetine Raw flags: sec3=Y Item: 281604051; group id 461; item number 1155; lccId None; manufacturer id BMP Source form: Cap; strength: 20mg Recorded listing: General benefit Source prices (unrounded): $0.3311; ministry $0.3311 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02448432 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=93412
Interchangeable products
AG-Fluoxetine · DIN 02485060 · $0.3311 Ach-Fluoxetine · DIN 02383241 · $0.3311 Apo-Fluoxetine · DIN 02216361 · $0.3311 Auro-Fluoxetine · DIN 02385635 · $0.3311 Co Fluoxetine · DIN 02242178 · $0.3311 Fluoxetine · DIN 02286076 · $0.3311 Fluoxetine · DIN 02374455 · $0.3311 Jamp-Fluoxetine · DIN 02386402 · $0.3311 M-Fluoxetine · DIN 02529440 · $0.3311 Mar-Fluoxetine · DIN 02392917 · $0.3311 Mint-Fluoxetine · DIN 02380579 · $0.3311 NRA-Fluoxetine · DIN 02503883 · $0.3311 PMS-Fluoxetine · DIN 02177587 · $0.3311 Prozac · DIN 00636622 · not recorded Ran-Fluoxetine · DIN 02405709 · $0.3311 Sandoz Fluoxetine · DIN 02479494 · $0.3311 Teva-Fluoxetine · DIN 02216590 · $0.3311
Shortage status: resolved shortage (ended 2025-03-07); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02448432
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Fluoxetine · DIN 02286076 · 20mg · capsule

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Fluoxetine · DIN 02286076 Manufacturer: Sanis Health Inc.; listing date 2011-08-04 Health Canada: Marketed since 2015-10-08 · brand FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 20 MG · company Sanis health inc · schedule Prescription
Check this DIN again · Health Canada product record

Fluoxetine: Formulary list price $0.3311/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.3311 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77155 · Verify on the e-Formulary ↗ (DIN 02286076)

Source record
DIN 02286076: Fluoxetine Raw flags: sec3=Y Item: 281604051; group id 461; item number 1155; lccId None; manufacturer id SAI Source form: Cap; strength: 20mg Recorded listing: General benefit Source prices (unrounded): $0.3311; ministry $0.3311 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02286076 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77155
Interchangeable products
AG-Fluoxetine · DIN 02485060 · $0.3311 Ach-Fluoxetine · DIN 02383241 · $0.3311 Apo-Fluoxetine · DIN 02216361 · $0.3311 Auro-Fluoxetine · DIN 02385635 · $0.3311 Bio-Fluoxetine · DIN 02448432 · $0.3311 Co Fluoxetine · DIN 02242178 · $0.3311 Fluoxetine · DIN 02374455 · $0.3311 Jamp-Fluoxetine · DIN 02386402 · $0.3311 M-Fluoxetine · DIN 02529440 · $0.3311 Mar-Fluoxetine · DIN 02392917 · $0.3311 Mint-Fluoxetine · DIN 02380579 · $0.3311 NRA-Fluoxetine · DIN 02503883 · $0.3311 PMS-Fluoxetine · DIN 02177587 · $0.3311 Prozac · DIN 00636622 · not recorded Ran-Fluoxetine · DIN 02405709 · $0.3311 Sandoz Fluoxetine · DIN 02479494 · $0.3311 Teva-Fluoxetine · DIN 02216590 · $0.3311
Shortage status: resolved shortage (ended 2026-04-28); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02286076
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Fluoxetine · DIN 02374455 · 20mg · capsule

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Fluoxetine · DIN 02374455 Manufacturer: Sivem Pharmaceuticals ULC; listing date 2021-02-26 Health Canada: Marketed since 2023-02-15 · brand FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 20 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Check this DIN again · Health Canada product record

Fluoxetine: Formulary list price $0.3311/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.3311 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85980 · Verify on the e-Formulary ↗ (DIN 02374455)

Source record
DIN 02374455: Fluoxetine Raw flags: sec3=Y Item: 281604051; group id 461; item number 1155; lccId None; manufacturer id SIV Source form: Cap; strength: 20mg Recorded listing: General benefit Source prices (unrounded): $0.3311; ministry $0.3311 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02374455 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85980
Interchangeable products
AG-Fluoxetine · DIN 02485060 · $0.3311 Ach-Fluoxetine · DIN 02383241 · $0.3311 Apo-Fluoxetine · DIN 02216361 · $0.3311 Auro-Fluoxetine · DIN 02385635 · $0.3311 Bio-Fluoxetine · DIN 02448432 · $0.3311 Co Fluoxetine · DIN 02242178 · $0.3311 Fluoxetine · DIN 02286076 · $0.3311 Jamp-Fluoxetine · DIN 02386402 · $0.3311 M-Fluoxetine · DIN 02529440 · $0.3311 Mar-Fluoxetine · DIN 02392917 · $0.3311 Mint-Fluoxetine · DIN 02380579 · $0.3311 NRA-Fluoxetine · DIN 02503883 · $0.3311 PMS-Fluoxetine · DIN 02177587 · $0.3311 Prozac · DIN 00636622 · not recorded Ran-Fluoxetine · DIN 02405709 · $0.3311 Sandoz Fluoxetine · DIN 02479494 · $0.3311 Teva-Fluoxetine · DIN 02216590 · $0.3311
Shortage status: resolved shortage (ended 2025-06-16); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02374455
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Jamp-Fluoxetine · DIN 02386402 · 20mg · capsule

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp-Fluoxetine · DIN 02386402 Manufacturer: Jamp Pharma Corporation; listing date 2012-08-27 Health Canada: Marketed since 2021-10-22 · brand JAMP-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 20 MG · company Jamp pharma corporation · schedule Prescription
Check this DIN again · Health Canada product record

Jamp-Fluoxetine: Formulary list price $0.3311/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.3311 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87199 · Verify on the e-Formulary ↗ (DIN 02386402)

Source record
DIN 02386402: Jamp-Fluoxetine Raw flags: sec3=Y Item: 281604051; group id 461; item number 1155; lccId None; manufacturer id JPC Source form: Cap; strength: 20mg Recorded listing: General benefit Source prices (unrounded): $0.3311; ministry $0.3311 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02386402 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87199
Interchangeable products
AG-Fluoxetine · DIN 02485060 · $0.3311 Ach-Fluoxetine · DIN 02383241 · $0.3311 Apo-Fluoxetine · DIN 02216361 · $0.3311 Auro-Fluoxetine · DIN 02385635 · $0.3311 Bio-Fluoxetine · DIN 02448432 · $0.3311 Co Fluoxetine · DIN 02242178 · $0.3311 Fluoxetine · DIN 02286076 · $0.3311 Fluoxetine · DIN 02374455 · $0.3311 M-Fluoxetine · DIN 02529440 · $0.3311 Mar-Fluoxetine · DIN 02392917 · $0.3311 Mint-Fluoxetine · DIN 02380579 · $0.3311 NRA-Fluoxetine · DIN 02503883 · $0.3311 PMS-Fluoxetine · DIN 02177587 · $0.3311 Prozac · DIN 00636622 · not recorded Ran-Fluoxetine · DIN 02405709 · $0.3311 Sandoz Fluoxetine · DIN 02479494 · $0.3311 Teva-Fluoxetine · DIN 02216590 · $0.3311
Shortage status: resolved shortage (ended 2026-07-02); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02386402
Shortage record checked 2026-09-13T08:10:21.292534+00:00

M-Fluoxetine · DIN 02529440 · 20mg · capsule

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
M-Fluoxetine · DIN 02529440 Manufacturer: Mantra Pharma Inc.; listing date 2023-04-28 Health Canada: Marketed since 2024-10-17 · brand M-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 20 MG · company Mantra pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

M-Fluoxetine: Formulary list price $0.3311/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.3311 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101865 · Verify on the e-Formulary ↗ (DIN 02529440)

Source record
DIN 02529440: M-Fluoxetine Raw flags: sec3=Y Item: 281604051; group id 461; item number 1155; lccId None; manufacturer id MAT Source form: Cap; strength: 20mg Recorded listing: General benefit Source prices (unrounded): $0.3311; ministry $0.3311 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02529440 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101865
Interchangeable products
AG-Fluoxetine · DIN 02485060 · $0.3311 Ach-Fluoxetine · DIN 02383241 · $0.3311 Apo-Fluoxetine · DIN 02216361 · $0.3311 Auro-Fluoxetine · DIN 02385635 · $0.3311 Bio-Fluoxetine · DIN 02448432 · $0.3311 Co Fluoxetine · DIN 02242178 · $0.3311 Fluoxetine · DIN 02286076 · $0.3311 Fluoxetine · DIN 02374455 · $0.3311 Jamp-Fluoxetine · DIN 02386402 · $0.3311 Mar-Fluoxetine · DIN 02392917 · $0.3311 Mint-Fluoxetine · DIN 02380579 · $0.3311 NRA-Fluoxetine · DIN 02503883 · $0.3311 PMS-Fluoxetine · DIN 02177587 · $0.3311 Prozac · DIN 00636622 · not recorded Ran-Fluoxetine · DIN 02405709 · $0.3311 Sandoz Fluoxetine · DIN 02479494 · $0.3311 Teva-Fluoxetine · DIN 02216590 · $0.3311
Shortage status: resolved shortage (ended 2025-05-30); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02529440
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Mar-Fluoxetine · DIN 02392917 · 20mg · capsule

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Mar-Fluoxetine · DIN 02392917 Manufacturer: Marcan Pharmaceuticals Inc.; listing date 2012-11-27 Health Canada: Marketed since 2025-03-21 · brand MAR-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 20 MG · company Marcan pharmaceuticals inc · schedule Prescription
Check this DIN again · Health Canada product record

Mar-Fluoxetine: Formulary list price $0.3311/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.3311 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87818 · Verify on the e-Formulary ↗ (DIN 02392917)

Source record
DIN 02392917: Mar-Fluoxetine Raw flags: sec3=Y Item: 281604051; group id 461; item number 1155; lccId None; manufacturer id MAR Source form: Cap; strength: 20mg Recorded listing: General benefit Source prices (unrounded): $0.3311; ministry $0.3311 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02392917 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87818
Interchangeable products
AG-Fluoxetine · DIN 02485060 · $0.3311 Ach-Fluoxetine · DIN 02383241 · $0.3311 Apo-Fluoxetine · DIN 02216361 · $0.3311 Auro-Fluoxetine · DIN 02385635 · $0.3311 Bio-Fluoxetine · DIN 02448432 · $0.3311 Co Fluoxetine · DIN 02242178 · $0.3311 Fluoxetine · DIN 02286076 · $0.3311 Fluoxetine · DIN 02374455 · $0.3311 Jamp-Fluoxetine · DIN 02386402 · $0.3311 M-Fluoxetine · DIN 02529440 · $0.3311 Mint-Fluoxetine · DIN 02380579 · $0.3311 NRA-Fluoxetine · DIN 02503883 · $0.3311 PMS-Fluoxetine · DIN 02177587 · $0.3311 Prozac · DIN 00636622 · not recorded Ran-Fluoxetine · DIN 02405709 · $0.3311 Sandoz Fluoxetine · DIN 02479494 · $0.3311 Teva-Fluoxetine · DIN 02216590 · $0.3311
Shortage status: discontinued (2017-04-01, reported by MARCAN PHARMACEUTICALS INC); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02392917
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Mint-Fluoxetine · DIN 02380579 · 20mg · capsule

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Mint-Fluoxetine · DIN 02380579 Manufacturer: Mint Pharmaceuticals Inc.; listing date 2012-05-29 Health Canada: Marketed since 2020-11-12 · brand MINT-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 20 MG · company Mint pharmaceuticals inc · schedule Prescription
Check this DIN again · Health Canada product record

Mint-Fluoxetine: Formulary list price $0.3311/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.3311 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=86636 · Verify on the e-Formulary ↗ (DIN 02380579)

Source record
DIN 02380579: Mint-Fluoxetine Raw flags: sec3=Y Item: 281604051; group id 461; item number 1155; lccId None; manufacturer id MIN Source form: Cap; strength: 20mg Recorded listing: General benefit Source prices (unrounded): $0.3311; ministry $0.3311 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02380579 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=86636
Interchangeable products
AG-Fluoxetine · DIN 02485060 · $0.3311 Ach-Fluoxetine · DIN 02383241 · $0.3311 Apo-Fluoxetine · DIN 02216361 · $0.3311 Auro-Fluoxetine · DIN 02385635 · $0.3311 Bio-Fluoxetine · DIN 02448432 · $0.3311 Co Fluoxetine · DIN 02242178 · $0.3311 Fluoxetine · DIN 02286076 · $0.3311 Fluoxetine · DIN 02374455 · $0.3311 Jamp-Fluoxetine · DIN 02386402 · $0.3311 M-Fluoxetine · DIN 02529440 · $0.3311 Mar-Fluoxetine · DIN 02392917 · $0.3311 NRA-Fluoxetine · DIN 02503883 · $0.3311 PMS-Fluoxetine · DIN 02177587 · $0.3311 Prozac · DIN 00636622 · not recorded Ran-Fluoxetine · DIN 02405709 · $0.3311 Sandoz Fluoxetine · DIN 02479494 · $0.3311 Teva-Fluoxetine · DIN 02216590 · $0.3311
Shortage status: resolved shortage (ended 2020-12-30); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02380579
Shortage record checked 2026-09-13T08:10:21.292534+00:00

NRA-Fluoxetine · DIN 02503883 · 20mg · capsule

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
NRA-Fluoxetine · DIN 02503883 Manufacturer: Nora Pharma; listing date 2021-01-29 Health Canada: Marketed since 2024-10-23 · brand NRA-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 20 MG · company Nora pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

NRA-Fluoxetine: Formulary list price $0.3311/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.3311 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99332 · Verify on the e-Formulary ↗ (DIN 02503883)

Source record
DIN 02503883: NRA-Fluoxetine Raw flags: sec3=Y Item: 281604051; group id 461; item number 1155; lccId None; manufacturer id NRA Source form: Cap; strength: 20mg Recorded listing: General benefit Source prices (unrounded): $0.3311; ministry $0.3311 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02503883 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99332
Interchangeable products
AG-Fluoxetine · DIN 02485060 · $0.3311 Ach-Fluoxetine · DIN 02383241 · $0.3311 Apo-Fluoxetine · DIN 02216361 · $0.3311 Auro-Fluoxetine · DIN 02385635 · $0.3311 Bio-Fluoxetine · DIN 02448432 · $0.3311 Co Fluoxetine · DIN 02242178 · $0.3311 Fluoxetine · DIN 02286076 · $0.3311 Fluoxetine · DIN 02374455 · $0.3311 Jamp-Fluoxetine · DIN 02386402 · $0.3311 M-Fluoxetine · DIN 02529440 · $0.3311 Mar-Fluoxetine · DIN 02392917 · $0.3311 Mint-Fluoxetine · DIN 02380579 · $0.3311 PMS-Fluoxetine · DIN 02177587 · $0.3311 Prozac · DIN 00636622 · not recorded Ran-Fluoxetine · DIN 02405709 · $0.3311 Sandoz Fluoxetine · DIN 02479494 · $0.3311 Teva-Fluoxetine · DIN 02216590 · $0.3311
Shortage status: resolved shortage (ended 2025-08-25); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02503883
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Ach-Fluoxetine · DIN 02393441 · 10mg · capsule

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Ach-Fluoxetine · DIN 02393441 Manufacturer: Accord Healthcare Inc.; listing date 2012-12-21 Health Canada: Marketed since 2019-09-04 · brand ACH-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 10 MG · company Accord healthcare inc · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87867 · Verify on the e-Formulary ↗ (DIN 02393441)

Source record
DIN 02393441: Ach-Fluoxetine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 281604122; group id 461; item number 1154; lccId None; manufacturer id ACH Source form: Cap; strength: 10mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $1.1773; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02393441 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87867
Interchangeable products
AG-Fluoxetine · DIN 02485052 · not recorded Apo-Fluoxetine · DIN 02216353 · not recorded Auro-Fluoxetine · DIN 02385627 · not recorded Bio-Fluoxetine · DIN 02448424 · not recorded Co Fluoxetine · DIN 02242177 · not recorded Fluoxetine · DIN 02286068 · not recorded Fluoxetine · DIN 02374447 · not recorded Jamp-Fluoxetine · DIN 02401894 · not recorded M-Fluoxetine · DIN 02529432 · not recorded Mar-Fluoxetine · DIN 02392909 · not recorded Mint-Fluoxetine · DIN 02380560 · not recorded NRA-Fluoxetine · DIN 02503875 · not recorded PMS-Fluoxetine · DIN 02177579 · not recorded Prozac · DIN 02018985 · not recorded Sandoz Fluoxetine · DIN 02479486 · not recorded Teva-Fluoxetine · DIN 02216582 · not recorded
Shortage status: active shortage (reported 2024-09-15, last updated 2025-04-07); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02393441
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Fluoxetine · DIN 02216353 · 10mg · capsule

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Fluoxetine · DIN 02216353 Manufacturer: Apotex Inc.; listing date 2008-02-12 Health Canada: Marketed since 2022-01-20 · brand APO-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 10 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19962 · Verify on the e-Formulary ↗ (DIN 02216353)

Source record
DIN 02216353: Apo-Fluoxetine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 281604122; group id 461; item number 1154; lccId None; manufacturer id APX Source form: Cap; strength: 10mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $1.1773; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02216353 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19962
Interchangeable products
AG-Fluoxetine · DIN 02485052 · not recorded Ach-Fluoxetine · DIN 02393441 · not recorded Auro-Fluoxetine · DIN 02385627 · not recorded Bio-Fluoxetine · DIN 02448424 · not recorded Co Fluoxetine · DIN 02242177 · not recorded Fluoxetine · DIN 02286068 · not recorded Fluoxetine · DIN 02374447 · not recorded Jamp-Fluoxetine · DIN 02401894 · not recorded M-Fluoxetine · DIN 02529432 · not recorded Mar-Fluoxetine · DIN 02392909 · not recorded Mint-Fluoxetine · DIN 02380560 · not recorded NRA-Fluoxetine · DIN 02503875 · not recorded PMS-Fluoxetine · DIN 02177579 · not recorded Prozac · DIN 02018985 · not recorded Sandoz Fluoxetine · DIN 02479486 · not recorded Teva-Fluoxetine · DIN 02216582 · not recorded
Shortage status: resolved shortage (ended 2026-03-12); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02216353
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Auro-Fluoxetine · DIN 02385627 · 10mg · capsule

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Auro-Fluoxetine · DIN 02385627 Manufacturer: Auro Pharma Inc.; listing date 2012-12-21 Health Canada: Marketed since 2012-07-24 · brand AURO-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 10 MG · company Auro pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87125 · Verify on the e-Formulary ↗ (DIN 02385627)

Source record
DIN 02385627: Auro-Fluoxetine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 281604122; group id 461; item number 1154; lccId None; manufacturer id AUR Source form: Cap; strength: 10mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $1.1773; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02385627 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87125
Interchangeable products
AG-Fluoxetine · DIN 02485052 · not recorded Ach-Fluoxetine · DIN 02393441 · not recorded Apo-Fluoxetine · DIN 02216353 · not recorded Bio-Fluoxetine · DIN 02448424 · not recorded Co Fluoxetine · DIN 02242177 · not recorded Fluoxetine · DIN 02286068 · not recorded Fluoxetine · DIN 02374447 · not recorded Jamp-Fluoxetine · DIN 02401894 · not recorded M-Fluoxetine · DIN 02529432 · not recorded Mar-Fluoxetine · DIN 02392909 · not recorded Mint-Fluoxetine · DIN 02380560 · not recorded NRA-Fluoxetine · DIN 02503875 · not recorded PMS-Fluoxetine · DIN 02177579 · not recorded Prozac · DIN 02018985 · not recorded Sandoz Fluoxetine · DIN 02479486 · not recorded Teva-Fluoxetine · DIN 02216582 · not recorded
Shortage status: resolved shortage (ended 2024-10-28); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02385627
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Bio-Fluoxetine · DIN 02448424 · 10mg · capsule

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Bio-Fluoxetine · DIN 02448424 Manufacturer: Biomed Pharma; listing date 2016-03-30 Health Canada: Marketed since 2024-12-05 · brand BIO-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 10 MG · company Biomed pharma · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=93411 · Verify on the e-Formulary ↗ (DIN 02448424)

Source record
DIN 02448424: Bio-Fluoxetine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 281604122; group id 461; item number 1154; lccId None; manufacturer id BMP Source form: Cap; strength: 10mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $1.1773; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02448424 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=93411
Interchangeable products
AG-Fluoxetine · DIN 02485052 · not recorded Ach-Fluoxetine · DIN 02393441 · not recorded Apo-Fluoxetine · DIN 02216353 · not recorded Auro-Fluoxetine · DIN 02385627 · not recorded Co Fluoxetine · DIN 02242177 · not recorded Fluoxetine · DIN 02286068 · not recorded Fluoxetine · DIN 02374447 · not recorded Jamp-Fluoxetine · DIN 02401894 · not recorded M-Fluoxetine · DIN 02529432 · not recorded Mar-Fluoxetine · DIN 02392909 · not recorded Mint-Fluoxetine · DIN 02380560 · not recorded NRA-Fluoxetine · DIN 02503875 · not recorded PMS-Fluoxetine · DIN 02177579 · not recorded Prozac · DIN 02018985 · not recorded Sandoz Fluoxetine · DIN 02479486 · not recorded Teva-Fluoxetine · DIN 02216582 · not recorded
Shortage status: resolved shortage (ended 2025-03-07); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02448424
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Fluoxetine · DIN 02286068 · 10mg · capsule

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Fluoxetine · DIN 02286068 Manufacturer: Sanis Health Inc.; listing date 2017-06-29 Health Canada: Marketed since 2017-01-27 · brand FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 10 MG · company Sanis health inc · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77154 · Verify on the e-Formulary ↗ (DIN 02286068)

Source record
DIN 02286068: Fluoxetine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 281604122; group id 461; item number 1154; lccId None; manufacturer id SAI Source form: Cap; strength: 10mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $1.1773; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02286068 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77154
Interchangeable products
AG-Fluoxetine · DIN 02485052 · not recorded Ach-Fluoxetine · DIN 02393441 · not recorded Apo-Fluoxetine · DIN 02216353 · not recorded Auro-Fluoxetine · DIN 02385627 · not recorded Bio-Fluoxetine · DIN 02448424 · not recorded Co Fluoxetine · DIN 02242177 · not recorded Fluoxetine · DIN 02374447 · not recorded Jamp-Fluoxetine · DIN 02401894 · not recorded M-Fluoxetine · DIN 02529432 · not recorded Mar-Fluoxetine · DIN 02392909 · not recorded Mint-Fluoxetine · DIN 02380560 · not recorded NRA-Fluoxetine · DIN 02503875 · not recorded PMS-Fluoxetine · DIN 02177579 · not recorded Prozac · DIN 02018985 · not recorded Sandoz Fluoxetine · DIN 02479486 · not recorded Teva-Fluoxetine · DIN 02216582 · not recorded
Shortage status: resolved shortage (ended 2026-04-28); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02286068
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Fluoxetine · DIN 02374447 · 10mg · capsule

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Fluoxetine · DIN 02374447 Manufacturer: Sivem Pharmaceuticals ULC; listing date 2021-02-26 Health Canada: Marketed since 2023-02-15 · brand FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 10 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85969 · Verify on the e-Formulary ↗ (DIN 02374447)

Source record
DIN 02374447: Fluoxetine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 281604122; group id 461; item number 1154; lccId None; manufacturer id SIV Source form: Cap; strength: 10mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $1.1773; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02374447 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85969
Interchangeable products
AG-Fluoxetine · DIN 02485052 · not recorded Ach-Fluoxetine · DIN 02393441 · not recorded Apo-Fluoxetine · DIN 02216353 · not recorded Auro-Fluoxetine · DIN 02385627 · not recorded Bio-Fluoxetine · DIN 02448424 · not recorded Co Fluoxetine · DIN 02242177 · not recorded Fluoxetine · DIN 02286068 · not recorded Jamp-Fluoxetine · DIN 02401894 · not recorded M-Fluoxetine · DIN 02529432 · not recorded Mar-Fluoxetine · DIN 02392909 · not recorded Mint-Fluoxetine · DIN 02380560 · not recorded NRA-Fluoxetine · DIN 02503875 · not recorded PMS-Fluoxetine · DIN 02177579 · not recorded Prozac · DIN 02018985 · not recorded Sandoz Fluoxetine · DIN 02479486 · not recorded Teva-Fluoxetine · DIN 02216582 · not recorded
Shortage status: resolved shortage (ended 2025-06-23); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02374447
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Jamp-Fluoxetine · DIN 02401894 · 10mg · capsule

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp-Fluoxetine · DIN 02401894 Manufacturer: Jamp Pharma Corporation; listing date 2013-06-27 Health Canada: Marketed since 2021-10-22 · brand JAMP-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 10 MG · company Jamp pharma corporation · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88677 · Verify on the e-Formulary ↗ (DIN 02401894)

Source record
DIN 02401894: Jamp-Fluoxetine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 281604122; group id 461; item number 1154; lccId None; manufacturer id JPC Source form: Cap; strength: 10mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $1.1773; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02401894 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88677
Interchangeable products
AG-Fluoxetine · DIN 02485052 · not recorded Ach-Fluoxetine · DIN 02393441 · not recorded Apo-Fluoxetine · DIN 02216353 · not recorded Auro-Fluoxetine · DIN 02385627 · not recorded Bio-Fluoxetine · DIN 02448424 · not recorded Co Fluoxetine · DIN 02242177 · not recorded Fluoxetine · DIN 02286068 · not recorded Fluoxetine · DIN 02374447 · not recorded M-Fluoxetine · DIN 02529432 · not recorded Mar-Fluoxetine · DIN 02392909 · not recorded Mint-Fluoxetine · DIN 02380560 · not recorded NRA-Fluoxetine · DIN 02503875 · not recorded PMS-Fluoxetine · DIN 02177579 · not recorded Prozac · DIN 02018985 · not recorded Sandoz Fluoxetine · DIN 02479486 · not recorded Teva-Fluoxetine · DIN 02216582 · not recorded
Shortage status: resolved shortage (ended 2026-07-02); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02401894
Shortage record checked 2026-09-13T08:10:21.292534+00:00

M-Fluoxetine · DIN 02529432 · 10mg · capsule

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
M-Fluoxetine · DIN 02529432 Manufacturer: Mantra Pharma Inc.; listing date 2023-03-31 Health Canada: Marketed since 2024-10-17 · brand M-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 10 MG · company Mantra pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101864 · Verify on the e-Formulary ↗ (DIN 02529432)

Source record
DIN 02529432: M-Fluoxetine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 281604122; group id 461; item number 1154; lccId None; manufacturer id MAT Source form: Cap; strength: 10mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $1.1773; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02529432 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101864
Interchangeable products
AG-Fluoxetine · DIN 02485052 · not recorded Ach-Fluoxetine · DIN 02393441 · not recorded Apo-Fluoxetine · DIN 02216353 · not recorded Auro-Fluoxetine · DIN 02385627 · not recorded Bio-Fluoxetine · DIN 02448424 · not recorded Co Fluoxetine · DIN 02242177 · not recorded Fluoxetine · DIN 02286068 · not recorded Fluoxetine · DIN 02374447 · not recorded Jamp-Fluoxetine · DIN 02401894 · not recorded Mar-Fluoxetine · DIN 02392909 · not recorded Mint-Fluoxetine · DIN 02380560 · not recorded NRA-Fluoxetine · DIN 02503875 · not recorded PMS-Fluoxetine · DIN 02177579 · not recorded Prozac · DIN 02018985 · not recorded Sandoz Fluoxetine · DIN 02479486 · not recorded Teva-Fluoxetine · DIN 02216582 · not recorded
Shortage status: resolved shortage (ended 2025-08-06); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02529432
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Mar-Fluoxetine · DIN 02392909 · 10mg · capsule

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Mar-Fluoxetine · DIN 02392909 Manufacturer: Marcan Pharmaceuticals Inc.; listing date 2012-11-27 Health Canada: Marketed since 2025-03-21 · brand MAR-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 10 MG · company Marcan pharmaceuticals inc · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87817 · Verify on the e-Formulary ↗ (DIN 02392909)

Source record
DIN 02392909: Mar-Fluoxetine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 281604122; group id 461; item number 1154; lccId None; manufacturer id MAR Source form: Cap; strength: 10mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $1.1773; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02392909 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87817
Interchangeable products
AG-Fluoxetine · DIN 02485052 · not recorded Ach-Fluoxetine · DIN 02393441 · not recorded Apo-Fluoxetine · DIN 02216353 · not recorded Auro-Fluoxetine · DIN 02385627 · not recorded Bio-Fluoxetine · DIN 02448424 · not recorded Co Fluoxetine · DIN 02242177 · not recorded Fluoxetine · DIN 02286068 · not recorded Fluoxetine · DIN 02374447 · not recorded Jamp-Fluoxetine · DIN 02401894 · not recorded M-Fluoxetine · DIN 02529432 · not recorded Mint-Fluoxetine · DIN 02380560 · not recorded NRA-Fluoxetine · DIN 02503875 · not recorded PMS-Fluoxetine · DIN 02177579 · not recorded Prozac · DIN 02018985 · not recorded Sandoz Fluoxetine · DIN 02479486 · not recorded Teva-Fluoxetine · DIN 02216582 · not recorded
Shortage status: discontinued (2017-04-01, reported by MARCAN PHARMACEUTICALS INC); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02392909
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Mint-Fluoxetine · DIN 02380560 · 10mg · capsule

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Mint-Fluoxetine · DIN 02380560 Manufacturer: Mint Pharmaceuticals Inc.; listing date 2012-05-29 Health Canada: Marketed since 2020-11-12 · brand MINT-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 10 MG · company Mint pharmaceuticals inc · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=86635 · Verify on the e-Formulary ↗ (DIN 02380560)

Source record
DIN 02380560: Mint-Fluoxetine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 281604122; group id 461; item number 1154; lccId None; manufacturer id MIN Source form: Cap; strength: 10mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $1.1773; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02380560 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=86635
Interchangeable products
AG-Fluoxetine · DIN 02485052 · not recorded Ach-Fluoxetine · DIN 02393441 · not recorded Apo-Fluoxetine · DIN 02216353 · not recorded Auro-Fluoxetine · DIN 02385627 · not recorded Bio-Fluoxetine · DIN 02448424 · not recorded Co Fluoxetine · DIN 02242177 · not recorded Fluoxetine · DIN 02286068 · not recorded Fluoxetine · DIN 02374447 · not recorded Jamp-Fluoxetine · DIN 02401894 · not recorded M-Fluoxetine · DIN 02529432 · not recorded Mar-Fluoxetine · DIN 02392909 · not recorded NRA-Fluoxetine · DIN 02503875 · not recorded PMS-Fluoxetine · DIN 02177579 · not recorded Prozac · DIN 02018985 · not recorded Sandoz Fluoxetine · DIN 02479486 · not recorded Teva-Fluoxetine · DIN 02216582 · not recorded
Shortage status: resolved shortage (ended 2020-12-30); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02380560
Shortage record checked 2026-09-13T08:10:21.292534+00:00

NRA-Fluoxetine · DIN 02503875 · 10mg · capsule

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
NRA-Fluoxetine · DIN 02503875 Manufacturer: Nora Pharma; listing date 2021-01-29 Health Canada: Marketed since 2024-10-23 · brand NRA-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 10 MG · company Nora pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99331 · Verify on the e-Formulary ↗ (DIN 02503875)

Source record
DIN 02503875: NRA-Fluoxetine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 281604122; group id 461; item number 1154; lccId None; manufacturer id NRA Source form: Cap; strength: 10mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $1.1773; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02503875 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99331
Interchangeable products
AG-Fluoxetine · DIN 02485052 · not recorded Ach-Fluoxetine · DIN 02393441 · not recorded Apo-Fluoxetine · DIN 02216353 · not recorded Auro-Fluoxetine · DIN 02385627 · not recorded Bio-Fluoxetine · DIN 02448424 · not recorded Co Fluoxetine · DIN 02242177 · not recorded Fluoxetine · DIN 02286068 · not recorded Fluoxetine · DIN 02374447 · not recorded Jamp-Fluoxetine · DIN 02401894 · not recorded M-Fluoxetine · DIN 02529432 · not recorded Mar-Fluoxetine · DIN 02392909 · not recorded Mint-Fluoxetine · DIN 02380560 · not recorded PMS-Fluoxetine · DIN 02177579 · not recorded Prozac · DIN 02018985 · not recorded Sandoz Fluoxetine · DIN 02479486 · not recorded Teva-Fluoxetine · DIN 02216582 · not recorded
Shortage status: resolved shortage (ended 2025-08-25); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02503875
Shortage record checked 2026-09-13T08:10:21.292534+00:00

PMS-Fluoxetine · DIN 02177579 · 10mg · capsule

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
PMS-Fluoxetine · DIN 02177579 Manufacturer: Pharmascience Inc.; listing date 2008-02-12 Health Canada: Marketed since 2001-12-22 · brand PMS-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 10 MG · company Pharmascience inc · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19074 · Verify on the e-Formulary ↗ (DIN 02177579)

Source record
DIN 02177579: PMS-Fluoxetine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 281604122; group id 461; item number 1154; lccId None; manufacturer id PMS Source form: Cap; strength: 10mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $1.1773; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02177579 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19074
Interchangeable products
AG-Fluoxetine · DIN 02485052 · not recorded Ach-Fluoxetine · DIN 02393441 · not recorded Apo-Fluoxetine · DIN 02216353 · not recorded Auro-Fluoxetine · DIN 02385627 · not recorded Bio-Fluoxetine · DIN 02448424 · not recorded Co Fluoxetine · DIN 02242177 · not recorded Fluoxetine · DIN 02286068 · not recorded Fluoxetine · DIN 02374447 · not recorded Jamp-Fluoxetine · DIN 02401894 · not recorded M-Fluoxetine · DIN 02529432 · not recorded Mar-Fluoxetine · DIN 02392909 · not recorded Mint-Fluoxetine · DIN 02380560 · not recorded NRA-Fluoxetine · DIN 02503875 · not recorded Prozac · DIN 02018985 · not recorded Sandoz Fluoxetine · DIN 02479486 · not recorded Teva-Fluoxetine · DIN 02216582 · not recorded
Shortage status: resolved shortage (ended 2023-11-10); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02177579
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Teva-Fluoxetine · DIN 02216582 · 10mg · capsule

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Teva-Fluoxetine · DIN 02216582 Manufacturer: Teva Canada Limited; listing date 2008-02-12 Health Canada: Marketed since 2010-10-09 · brand TEVA-FLUOXETINE · ATC N06AB03 FLUOXETINE · form Capsule · route Oral · ingredients FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 10 MG · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19916 · Verify on the e-Formulary ↗ (DIN 02216582)

Source record
DIN 02216582: Teva-Fluoxetine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 281604122; group id 461; item number 1154; lccId None; manufacturer id TEV Source form: Cap; strength: 10mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $1.1773; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02216582 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19916
Interchangeable products
AG-Fluoxetine · DIN 02485052 · not recorded Ach-Fluoxetine · DIN 02393441 · not recorded Apo-Fluoxetine · DIN 02216353 · not recorded Auro-Fluoxetine · DIN 02385627 · not recorded Bio-Fluoxetine · DIN 02448424 · not recorded Co Fluoxetine · DIN 02242177 · not recorded Fluoxetine · DIN 02286068 · not recorded Fluoxetine · DIN 02374447 · not recorded Jamp-Fluoxetine · DIN 02401894 · not recorded M-Fluoxetine · DIN 02529432 · not recorded Mar-Fluoxetine · DIN 02392909 · not recorded Mint-Fluoxetine · DIN 02380560 · not recorded NRA-Fluoxetine · DIN 02503875 · not recorded PMS-Fluoxetine · DIN 02177579 · not recorded Prozac · DIN 02018985 · not recorded Sandoz Fluoxetine · DIN 02479486 · not recorded
Shortage status: resolved shortage (ended 2025-11-25); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02216582
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Other drugs in the same formulary class (28:16:04 Antidepressants) and how they are covered

Matched class: 28:16:04 Antidepressants

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: AMITRIPTYLINE, CLOMIPRAMINE HCL, FLUVOXAMINE MALEATE, NORTRIPTYLINE, PHENELZINE SULFATE, SERTRALINE HCL, TRANYLCYPROMINE SULFATE, VENLAFAXINE HCL, VORTIOXETINE HYDROBROMIDE Some products covered without a code (check the product listing): CITALOPRAM HYDROBROMIDE, DESIPRAMINE, DOXEPIN HCL, DULOXETINE, ESCITALOPRAM, IMIPRAMINE, MIRTAZAPINE, MOCLOBEMIDE, PAROXETINE HCL, TRAZODONE HYDROCHLORIDE, TRIMIPRAMINE 28:16:04 Antidepressants

CITALOPRAM HYDROBROMIDE

· 51 products · Off-Formulary Interchangeable, not an ODB benefit (9), General benefit (42) · strengths: 10mg, 20mg, 40mg · Tab

ESCITALOPRAM

· 40 products · Listed, not a benefit (2), General benefit (38) · strengths: 10mg, 20mg · Orally Disintegrating Tab, Orally Disintegrating Tablet, Tab

FLUVOXAMINE MALEATE

· 6 products · General benefit · strengths: 50mg, 100mg · Tab

PAROXETINE HCL

· 47 products · Off-Formulary Interchangeable, not an ODB benefit (16), General benefit (31) · strengths: 10mg, 20mg, 30mg · Tab

SERTRALINE HCL

· 49 products · General benefit · strengths: 25mg, 50mg, 100mg · Cap

AMITRIPTYLINE

· 12 products · General benefit · strengths: 10mg, 25mg, 50mg · Tab

CLOMIPRAMINE HCL

· 5 products · General benefit · strengths: 25mg, 50mg, 10mg · Tab

DESIPRAMINE

· 7 products · Listed, not a benefit (4), General benefit (3) · strengths: 25mg, 50mg, 75mg · Tab

DOXEPIN HCL

· 20 products · General benefit (12), Off-Formulary Interchangeable, not an ODB benefit (8) · strengths: 10mg, 25mg, 50mg, 75mg, 100mg · Cap

DULOXETINE

· 38 products · Listed, not a benefit (2), General benefit (36) · strengths: 30mg, 60mg · DR Cap

IMIPRAMINE

· 9 products · Listed, not a benefit (3), General benefit (6) · strengths: 10mg, 25mg, 50mg · Tab

MIRTAZAPINE

· 25 products · General benefit (16), Off-Formulary Interchangeable, not an ODB benefit (9) · strengths: 15mg, 30mg, 45mg · Orally Disintegrating Tab, Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 28:16:04 and 12 more
Full class listing Related classes: 28:08:04 Nonsteroidal Anti-Inflammatory Agents, 28:08:08 Opiate Agonists, 28:08:12 Opiate Partial Agonists, 28:08:92 Miscellaneous Analgesics and Antipyretics, 28:16:08 Tranquilizers, 28:16:12 Other Psychotropics, 28:36:08 Anticholinergic Agents, 28:36:20 Dopamine Receptor Agonists Same formulary class, not same indication: class membership alone does not establish equivalent uses.
Other drugs whose Health Canada label lists a similar indication: major depressive disorder, obsessive-compulsive disorder
From Health Canada product monographs; label wording only, not a treatment recommendation. Matching is lexical and uses one held product label per generic; formulations and qualifying criteria may differ. Covered without a code on the Ontario formulary: BREXPIPRAZOLE, FLUVOXAMINE MALEATE, SERTRALINE HCL, VORTIOXETINE HYDROBROMIDE BREXPIPRAZOLE · General benefit • use as an adjunct to antidepressants for the treatment of major depressive disorder (MDD) in adult patients with an inadequate response to prior antidepressant treatments during the current episode (see 14.1 Clinical Trials by Indication, Adjunctive Treatment in Major Depressive Disorder (MDD). PM: https://pdf.hres.ca/dpd_pm/00074327.PDF; date February 16, 2017; DIN 02461749; fetched 2026-09-10 Product monograph DESVENLAFAXINE · Off-Formulary Interchangeable, not an ODB benefit 1 INDICATIONS PRISTIQ (desvenlafaxine succinate) is indicated for: • symptomatic relief of major depressive disorder in adults. PM: https://pdf.hres.ca/dpd_pm/00074568.PDF; date FEB 04, 2009; DIN 02321092; fetched 2026-09-10 Product monograph DULOXETINE · Listed, not a benefit (2), General benefit (36) 1 Indications pms-DULOXETINE (Duloxetine Delayed-Release Capsules) is indicated in adults for: • Major Depressive Disorder pms-DULOXETINE is indicated for the symptomatic relief of major depressive disorder (MDD). PM: https://pdf.hres.ca/dpd_pm/00084896.PDF; date 2026-05-29; DIN 02429446; fetched 2026-09-10 Product monograph FLUVOXAMINE MALEATE · General benefit  Obsessive-Compulsive Disorder: PM: https://pdf.hres.ca/dpd_pm/00062197.PDF; date JAN 9, 1991; DIN 01919342; fetched 2026-09-10 Product monograph SERTRALINE HCL · General benefit Therefore, the health professional who elects to use ZOLOFT for extended periods should periodically reevaluate the long-term usefulness of the drug for the individual patient.  Obsessive-Compulsive Disorder ZOLOFT is indicated for the symptomatic relief of obsessive-compulsive disorder (OCD). PM: https://pdf.hres.ca/dpd_pm/00072140.PDF; date AUG 22, 2023; DIN 01962779; fetched 2026-09-10 Product monograph VILAZODONE HYDROCHLORIDE · Off-Formulary Interchangeable, not an ODB benefit 1 INDICATIONS VIIBRYD (vilazodone hydrochloride tablets) is indicated for the symptomatic relief of Major Depressive Disorder (MDD). PM: https://pdf.hres.ca/dpd_pm/00073801.PDF; date JUL 15, 2015; DIN 02443724; fetched 2026-09-10 Product monograph VORTIOXETINE HYDROBROMIDE · General benefit 1 Indications TRINTELLIX (vortioxetine hydrobromide) is indicated for: • the treatment of major depressive disorder (MDD) in adults. PM: https://pdf.hres.ca/dpd_pm/00085298.PDF; date 2026-07-10; DIN 02432919; fetched 2026-09-10 Product monograph Coverage source: ON formulary extract 2026-08-26
What the Health Canada label says it is for
1 INDICATIONS pms-FLUOXETINE (fluoxetine) is indicated in adults for: • Depression: pms-FLUOXETINE is indicated for the symptomatic relief of Major Depressive Disorder (MDD). • Bulimia Nervosa: Fluoxetine has been shown to significantly decrease binge-eating and purging activity when compared with placebo treatment. • Obsessive-Compulsive Disorder (OCD): pms-FLUOXETINE is indicated for the symptomatic treatment of obsessive-compulsive disorder (OCD). The obsessions or compulsions must be experienced as intrusive, markedly distressing, time consuming, or interfering significantly with the person’s social or occupational functioning. The efficacy of fluoxetine in hospitalized patients has not been adequately studied. Long-term use of fluoxetine: The effectiveness of fluoxetine in long-term use in bulimia nervosa (i.e., for more than 16 weeks) and in obsessive-compulsive disorder (i.e., for more than 13 weeks) has not been systematically evaluated in controlled trials. Therefore, the health professional who elects to use pms-FLUOXETINE in these indications for extended periods … https://pdf.hres.ca/dpd_pm/00076968.PDF PM date: AUG 30, 2024 Source product: PMS-FLUOXETINE; DIN 02177579; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Ach-Fluoxetine · DIN 02383241 Shortage status: active shortage (reported 2024-08-20, last updated 2025-04-07); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02383241

Check this DIN again

Mar-Fluoxetine · DIN 02392917 Shortage status: discontinued (2017-04-01, reported by MARCAN PHARMACEUTICALS INC); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02392917

Check this DIN again

Ach-Fluoxetine · DIN 02393441 Shortage status: active shortage (reported 2024-09-15, last updated 2025-04-07); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02393441

Check this DIN again

Mar-Fluoxetine · DIN 02392909 Shortage status: discontinued (2017-04-01, reported by MARCAN PHARMACEUTICALS INC); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02392909

Check this DIN again

Other review policies

For Ach-Fluoxetine, Apo-Fluoxetine, Auro-Fluoxetine, Bio-Fluoxetine, Fluoxetine, Jamp-Fluoxetine, M-Fluoxetine, Mar-Fluoxetine, Mint-Fluoxetine, NRA-Fluoxetine, PMS-Fluoxetine, Teva-Fluoxetine: no applicable EAP criteria are held and no ODB benefit is established. These policies do not establish coverage.

For rare, immediately life-, limb- or organ-threatening circumstances, the Compassionate Review Policy may consider an unfunded drug or indication, subject to its criteria and without bypassing the drug review process. Compassionate Review Policy

Compassionate Review Policy: source quote
Where there are rare clinical circumstances in immediately life, limb, or organ-threatening conditions, the Executive Officer will also consider requests for drugs or indications in situations where there has not been a decision by the Executive Officer to provide funding of the drug or indication as part of the Ontario Drug Benefit program (and the EAP), and the drug or indication requested would not circumvent the established review process for new drugs or indications as part of the drug submission process for listing within the Ontario Drug Benefit program. Requests must meet the criteria for the Compassionate Review Policy.

Ontario source; updated September 15, 2026

For cancer drugs, Case-by-Case Review considers rare, immediately life-threatening circumstances when no satisfactory funded treatment exists; its criteria and application process apply. Case-by-Case Review (cancer drugs)

Case-by-Case Review (cancer drugs): source quote
Note: Requests for cancer drugs are considered under the Case-by-Case Review Program (CBCRP) which is administered by Ontario Health (Cancer Care Ontario) on behalf of the Ministry of Health. The CBCRP considers funding requests for drugs (both oral therapies and injectable drugs) for the treatment of cancer in patients who have a rare clinical circumstance that is immediately life-threatening (death is likely within a matter of months) and who require treatment with an unfunded drug, because there is no other satisfactory and funded treatment. Please refer to the Ontario Health website for information on the application process, FAQs, eligibility criteria and program policies.

Ontario source; updated September 15, 2026